Artificial Intelligence in Pharmacovigilance: Guiding Principles from the CIOMS Working Group XIV

• G. Niklas NorénUppsala Monitoring Centre
• Julie DurandEuropean Medicines Agency
• Vijay KaraGlaxoSmithKline (United Kingdom)
• Elizabeth MacEntee PileggiJohnson & Johnson (United States)
• Hua CarrollBiogen (United States)
• Sanna HillCouncil for International Organizations of Medical Sciences
• Manfred HaubenMerck Healthcare Germany GmbH (Germany)
• Taxiarchis BotsisJohns Hopkins University
• Lembit RägoCouncil for International Organizations of Medical Sciences
• CIOMS Working Group XIV
• Russ Biagio Altman
• Taxiarchis BotsisJohns Hopkins University
• Jean‐Michel Dogné
• Justyna Amelio
• Luisa Fernanda Barrios Martinez
• Andrew Bate
• Arvind Bellur
• Adrian Berridge
• Hua CarrollBiogen (United States)
• Yauheniya Cherkas
• Selin Cooper
• Mariane Diniz
• Douglas Domalik
• Piero Francesco Franco
• Julie Girod
• Neal Grabowski
• Manfred HaubenMerck Healthcare Germany GmbH (Germany)
• Thomas Henn
• Vijay KaraGlaxoSmithKline (United Kingdom)
• Dieter Kempf
• Kostadinos Kidos
• Denny Lorenz
• Elizabeth MacEntee PileggiJohnson & Johnson (United States)
• Ravi Patel
• John Reinhard Pietzsch
• H.‐J. Römming
• Walter Straus
• James Whitehead
• Brian Buch
• Julie DurandEuropean Medicines Agency
• Kirsten Egebjerg Juul
• Kendal Harrison
• Satoko Hirokawa-Voorburg
• Alexander Horst
• Morten Jensen
• Jesper Kjær
• Benny Ling
• Mônica da Luz Carvalho Soares
• Yusuke Matsunaga
• Dirk Mentzer
• Manuela Messelhäußer
• Flávia Moreira Cruz
• Nicolas Perez
• Irene Scholz
• Thomas Stammschulte
• Phil Tregunno
• Roli Mathur
• Eva-Lisa Meldau
• G. Niklas NorénUppsala Monitoring Centre
• Stephen Rosenfeld
• Brian Yau
• Stephen Heaton
• Sanna HillCouncil for International Organizations of Medical Sciences
• Hervé Le Louët
• Lembit RägoCouncil for International Organizations of Medical Sciences
• Kateriina Rannula
• Panos Tsintis